About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
First report of dolutegravir unbond plasma concentrations during pregnancy in HIV-positive women
Elvitegravir pharmacokinetics during pregnancy and postpartum
REVIVE Webinar: Development of antibacterial drugs targeting specific pathogens
Human Immunodeficiency Virus (HIV) – Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children
AIDS 2018: Accelerating the development and uptake of the most needed drug formulations for children
WHO: interim guidance policy brief publication
PED-MERMAIDS has reached 50% of enrollment target!
HIV specific IgM memory B-cells dominate in seronegative early-treated children